Chemicals Sector Playbook
This playbook covers the Chemicals sector of the Indian stock market. Use it to understand how companies in this sector make money, what metrics matter most,...
Sector Overview
This playbook covers the Chemicals sector of the Indian stock market. Use it to understand how companies in this sector make money, what metrics matter most, and how to value them.
What you will learn
- Business Model: Commodity chemicals vs specialty chemicals — margin profiles and moats
- China+1 Opportunity: India's chemical manufacturing advantage, anti-dumping duties, supply chain shift
- Capacity & Utilization: Capex cycles, brownfield vs greenfield, utilization rates and operating leverage
- Raw Material Dynamics: Crude oil derivatives, feedstock integration, margin volatility
- Valuation: Normalized earnings, replacement cost, and specialty premium multiples
Sub-industries in this sector
| Basic Industry | Playbook |
|---|---|
| Carbon Black | View playbook |
| Commodity Chemicals | View playbook |
| Dyes And Pigments | View playbook |
| Explosives | View playbook |
| Fertilizers | View playbook |
| Industrial Gases | View playbook |
| Pesticides & Agrochemicals | View playbook |
| Petrochemicals | View playbook |
| Printing Inks | View playbook |
| Specialty Chemicals | View playbook |
| Trading - Chemicals | View playbook |
How to use this playbook
Start with the Business Model lesson to understand how companies in this sector generate revenue. Then move through metrics, risks, and valuation in sequence. Each lesson builds on the previous one.
1. Chemicals — Business Model
What you will learn
- The critical difference between commodity and specialty chemicals
- How value chain position determines pricing power and margins
- Why backward integration is the #1 moat in Indian chemicals
- Revenue models: volume-driven vs spread-driven vs contract manufacturing
The chemical industry spectrum
India's chemical industry is $220 Bn (₹18+ lakh crore) — 6th largest globally. The sector ranges from basic petrochemicals to highly specialized molecules supplying pharma and agri innovators.
Business model types
Type 1: Commodity chemicals (spread-based)
Revenue = Volume × (Market Price - Raw Material Cost). No pricing power — prices move with global benchmarks.
| Company | Product | Revenue (FY24) | EBITDA Margin | Model |
|---|---|---|---|---|
| Tata Chemicals | Soda ash, bicarb | ₹16,000 Cr | 18-20% | Capacity + cost advantage |
| GACL | Caustic soda, chlor-alkali | ₹3,800 Cr | 15-18% | Integration + power cost |
| DCM Shriram | Chlor-vinyl, PVC | ₹10,000 Cr | 14-16% | Backward integration |
Type 2: Specialty chemicals (application-based)
Revenue = Volume × Premium Pricing (based on application value, not raw material). Strong pricing power.
| Company | Specialization | Revenue (FY24) | EBITDA Margin | Moat |
|---|---|---|---|---|
| SRF | Fluoro-specialty, packaging | ₹14,500 Cr | 22-25% | Fluorine chemistry, scale |
| PI Industries | CRAMS + agri actives | ₹7,800 Cr | 23-26% | Innovator relationships |
| Navin Fluorine | Fluorochemicals, CRAMS | ₹2,200 Cr | 22-25% | Fluorine expertise, HPP |
| Clean Science | Performance chemicals | ₹750 Cr | 35-40% | Process patents, zero-waste |
Type 3: Contract manufacturing (CRAMS/CSM)
Revenue = Long-term contracts with global innovators (Syngenta, BASF, Bayer). Multi-year revenue visibility.
CRAMS moat
Once a molecule is qualified with a customer (6-18 month validation), switching costs are very high. The customer rarely moves — creating annuity-like revenue for 5-10 years per molecule.
Value chain positions and margin profiles
| Position | Examples | Gross Margin | EBITDA | Capital Intensity |
|---|---|---|---|---|
| Basic (upstream) | Reliance (ethylene), IOCL (naphtha) | 15-20% | 8-12% | Very high |
| Intermediate | GNFC (TDI), Deepak Nitrite (phenol) | 20-30% | 14-20% | High |
| Fine/specialty (downstream) | Aarti Industries, SRF | 30-45% | 20-28% | Moderate |
| CRAMS/custom synthesis | PI Industries, Navin Fluorine | 40-55% | 25-40% | Moderate-high |
Backward integration — the chemical company moat
More backward integration = More margin stability. A company that starts from basic feedstock captures 2-3× more EBITDA per unit than one buying intermediates.
Backward integration examples
| Company | Starting Material | End Product | Integration Benefit |
|---|---|---|---|
| Aarti Industries | Benzene/toluene | Specialty amines, nitro compounds | Controls 70%+ of value chain |
| Deepak Nitrite | Phenol (own manufacture) | Acetone, IPA, downstream | Phenol self-supply = ₹500 Cr margin benefit |
| SRF | Fluorspar → HF → Refrigerants → Fluoro-specialties | Full chain | Captured entire fluorine value chain |
Revenue drivers to track
| Driver | Commodity Chemical | Specialty Chemical |
|---|---|---|
| Volume growth | Primary driver (capacity additions) | Secondary (application wins matter more) |
| Realizations | Market-driven (no control) | Customer-driven (application value) |
| Mix improvement | Limited (fungible product) | Key lever (move to higher-value molecules) |
| Contract tenure | Spot or quarterly | Multi-year (3-7 years typical) |
| Customer stickiness | Low (switch on price) | Very high (qualification + validation) |
Indian context
🗣️
"Chemical sector mein commodity aur specialty ka farak samajhna sabse zaroori hai. Commodity mein spread dekhna — jab raw material sasta aur product mehnga, tabhi margin aata hai. Specialty mein customer relationship aur process complexity hi moat hai."
✅ Checklist
- ○I can classify a chemical company as commodity, intermediate, specialty, or CRAMS
- ○I understand why backward integration creates a moat
- ○I know the typical EBITDA margin bands for each category
- ○I can identify whether revenue is spread-driven or contract-driven
Key takeaway
Indian chemicals is a two-speed sector: commodity players are price-takers dependent on global cycles; specialty/CRAMS players have pricing power, multi-year contracts, and 2-3× higher margins. The best investments are in companies moving UP the value chain — from commodity to specialty, from domestic to export, from spot pricing to long-term contracts.
2. Chemicals — China+1 Opportunity
Why global chemical supply chains are diversifying away from China India's specific advantages (and gaps) in capturing this shift Which subsegments and compa...
Full sector playbook is a Pro feature
Sign up to continue learning — unlock the full path, in-depth lessons, projects, and every tool on the platform.
3. Chemicals — Capacity & Utilization
How capex cycles drive chemical company earnings (boombust) Brownfield vs greenfield — risk, timeline, and return differences Why utilization rate is the mos...
Full sector playbook is a Pro feature
Sign up to continue learning — unlock the full path, in-depth lessons, projects, and every tool on the platform.
4. Chemicals — Raw Material Dynamics
How crude oil flows through to chemical industry costs Key feedstock chains: naphtha → ethylene, benzene → downstream Why some companies are insulated and ot...
Full sector playbook is a Pro feature
Sign up to continue learning — unlock the full path, in-depth lessons, projects, and every tool on the platform.
5. Chemicals — Valuation
Why chemical sector valuation requires cycle normalization Different valuation frameworks for commodity vs specialty vs CRAMS How to use replacement cost as...
Full sector playbook is a Pro feature
Sign up to continue learning — unlock the full path, in-depth lessons, projects, and every tool on the platform.